(Q83284544)
Statements
A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC) (English)
M A Socinski
M N Saleh
D F Trent
T W Dobbs
L M Zehngebot
M A Levine
R Bordoni